Exane Derivatives’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $208 | Sell |
3
-786
| -100% | -$54.5K | ﹤0.01% | 669 |
|
|
2022
Q1 | $65.4K | Sell |
789
-161
| -17% | -$13.3K | 0.02% | 538 |
|
|
2021
Q4 | $71.3K | Sell |
950
-284
| -23% | -$21.3K | 0.02% | 465 |
|
|
2021
Q3 | $143K | Sell |
1,234
-204
| -14% | -$23.7K | 0.03% | 460 |
|
|
2021
Q2 | $271K | Sell |
1,438
-452
| -24% | -$85.2K | 0.06% | 307 |
|
|
2021
Q1 | $250K | Sell |
1,890
-819
| -30% | -$108K | 0.07% | 259 |
|
|
2020
Q4 | $469K | Buy |
+2,709
| New | +$469K | 0.14% | 168 |
|